Skip to main content
Premium Trial:

Request an Annual Quote

Metamark Inks Deal with Highmark Blue Shield for Coverage of Urology Dx

NEW YORK (GenomeWeb) – Metamark today announced that it has signed an agreement to provide its suite of urology diagnostics to 5.2 million Highmark Blue Shield members in Delaware, Pennsylvania, and West Virginia.

Cambridge, Mass.-based Metamark provides a comprehensive suite of diagnostic and prognostic tools for urology, including the Promark prostate cancer panel.

"There is increasing awareness among payers regarding the potential for new diagnostic tools to improve patient care and decrease healthcare costs," Metamark CEO Shawn Marcell said in a statement. "Metamark is at the forefront of this transformation, taking a comprehensive approach to the disease that combines our deep uropathology expertise with tests that help urologists to make more personalized treatment decisions for their patients."

Financial and other details of the agreement were not disclosed.

In December 2014 Metamark's laboratory received accreditation from theCollegeofAmerican Pathologists.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.